Citius Oncology (CTOR) Inventory (2024 - 2026)

Citius Oncology (CTOR) has reported Inventory for 3 consecutive years, with $22.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Inventory rose 31.48% year-over-year to $22.6 million in Q2 2026; TTM through Jun 2026 was $22.6 million, a 31.48% increase from a year earlier, with the FY2025 full-year figure at $22.3 million, up 169.53% from the prior year.
• Inventory was $22.6 million for Q2 2026 at Citius Oncology, roughly flat from $22.7 million in the prior quarter.
• Over five years, Inventory peaked at $22.7 million in Q1 2026 and troughed at $8.3 million in Q3 2024.
• A 3-year average of $18.2 million and a median of $19.7 million in 2025 frame the typical range for Inventory.
• Across the five-year window, Inventory jumped 169.53% in 2025 and soared 31.48% in 2026, its largest moves.
• Over 3 years, Inventory stood at $14.4 million in 2024, then jumped by 57.42% to $22.6 million in 2025, then retreated by 0.06% to $22.6 million in 2026.
• The last three Inventory figures came in at $22.6 million (Q2 2026), $22.7 million (Q1 2026), and $22.6 million (Q4 2025), per Business Quant data.